Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

1.7K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.7K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

456
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
456
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

763
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
763
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

473
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
473
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

4.0K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is There a Golden Hour for Thrombectomy in Intermediate-Risk Pulmonary Embolism? Insights From SYMPHONY-PE.

Circulation. Cardiovascular interventions·2026
Same author

C-Reactive Protein and Long-Term Risk of Death in Patients with Myocardial Infarction.

Cardiology·2026
Same author

Real-world analysis of outcomes of patients undergoing coronary intravascular lithotripsy versus atherectomy for calcified coronary artery disease: findings from the TriNetX database.

The Journal of invasive cardiology·2026
Same author

Ischemic Stroke Polygenic Risk Score and Recurrent Cardiac and Cerebrovascular Events After Coronary Artery Revascularization.

European journal of preventive cardiology·2026
Same author

Cardiovascular Outcomes With GLP-1 Receptor Agonists in Patients With Diabetes or Obesity Undergoing Transcatheter Aortic Valve Replacement.

The Canadian journal of cardiology·2026
Same author

Development of an Integrated Monogenic and Polygenic Risk Assessment Tool for Coronary Artery Disease and Its Application in a Community-Based Health Care Biobank.

Circulation. Genomic and precision medicine·2026

Related Experiment Video

Updated: Apr 6, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.8K

Culprit-Only vs. Complete Revascularization During ST-Segment Elevation Myocardial Infarction.

Arman Qamar1, Deepak L Bhatt1

  • 1Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA 02115, USA.

Progress in Cardiovascular Diseases
|July 25, 2015
PubMed
Summary

Complete revascularization may benefit ST-segment elevation myocardial infarction (STEMI) patients with multivessel disease and non-culprit lesions. However, further large trials are needed to confirm outcomes and optimal timing for staged procedures.

Keywords:
Complete revascularizationMultivessel diseasePCISTEMI

More Related Videos

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.9K
Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.4K

Related Experiment Videos

Last Updated: Apr 6, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.8K
A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.9K
Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.4K

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • ST-segment elevation myocardial infarction (STEMI) patients often have multivessel disease with non-culprit lesions.
  • Current guidelines generally do not recommend routine revascularization of these non-culprit lesions.
  • Previous studies on revascularization strategies in STEMI with multivessel disease have yielded conflicting results.

Purpose of the Study:

  • To evaluate the optimal revascularization strategy for STEMI patients with obstructive non-culprit lesions.
  • To assess the impact of complete revascularization versus culprit-lesion-only revascularization on major adverse cardiac events.
  • To determine the ideal timing for staged revascularization procedures.

Main Methods:

  • Review of recent randomized controlled trials (RCTs) including PRAMI, CvLPRIT, and DANAMI-3-PRIMULTI.
  • Analysis of data from observational studies and smaller RCTs.
  • Focus on STEMI patients undergoing primary percutaneous coronary intervention (PCI) with multivessel disease.

Main Results:

  • Recent RCTs suggest a potential benefit of complete revascularization in STEMI patients with non-culprit lesions.
  • Conflicting results exist from prior smaller studies.
  • Further large-scale RCT data are required to definitively establish benefits and optimal timing.

Conclusions:

  • Complete revascularization may be beneficial for select STEMI patients with multivessel disease and non-culprit lesions.
  • A personalized approach is currently recommended for revascularization strategy.
  • More robust evidence from large RCTs is necessary to guide definitive treatment guidelines.